- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02877953
Transitional Care Interventions for Patients With Cirrhosis Post-TIPS
August 23, 2016 updated by: HOU Wei-wei, Shihezi University
Transitional Care Interventions Post-TIPS
The investigators conducted a randomized controlled trial to describe if multidisciplinary and patient-centered transitional care interventions for patients with cirrhosis post-TIPS can improve compliance behavior and reduce complications post-TIPS after discharge.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
76
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Clinical diagnosis of diagnosis of cirrhosis;
- Child-Pugh Score <10;
- Informed Consent.
Exclusion Criteria:
- Age <18 years;
- Right ventricular failure;
- Severe systemic infection;
- Hepatocellular carcinoma (HCC);
- Terminal disease; and
- Failure to provide written consent to participate in the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control group
The conventional care was performed for the patients of control group
|
|
|
Experimental: Intervention group
the prevention of complications post-TIPS
|
Continuous nursing through telephone follow-up, family visits, and WeChat guided patients to prevent gastrointestinal bleeding, infection and constipation ,intake quality low-protein diet, recognize minimal encephalopathy, monitor blood ammonia, return visit regularly, deal with adverse drug reactions of anticoagulant.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The compliance behavior associated with complications post-TIPS
Time Frame: 1 and 3 months after discharge
|
It was surveyed using a self-designed questionnaire based on evidence.
The questionnaire includes 6 items that address taking medicine on time, quality low-protein diet intake, going to sleep at a regular time, moderate exercise, emotion regulation, regular follow-up.
Item responses are on a 4-point scale (0 = never to 3 = always).
Data were collected by face-to-face interviews with trained transition nurses.
Change is being assessed
|
1 and 3 months after discharge
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
incidence of adverse events (shunt dysfunction and hepatic encephalopathy)
Time Frame: 1 and 3 months after discharge
|
Change is being assessed
|
1 and 3 months after discharge
|
|
Child-Pugh scores
Time Frame: Baseline, 1 and 3 months after discharge
|
Change is being assessed
|
Baseline, 1 and 3 months after discharge
|
|
Blood ammonia levels
Time Frame: Baseline, 1 and 3 months after discharge
|
Change is being assessed
|
Baseline, 1 and 3 months after discharge
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2013
Primary Completion (Actual)
September 1, 2015
Study Registration Dates
First Submitted
August 16, 2016
First Submitted That Met QC Criteria
August 23, 2016
First Posted (Estimate)
August 24, 2016
Study Record Updates
Last Update Posted (Estimate)
August 24, 2016
Last Update Submitted That Met QC Criteria
August 23, 2016
Last Verified
August 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- TCI-2016
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
According to the actual situation to decide whether to share data
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fibrosis
-
Royal Brompton & Harefield NHS Foundation TrustRecruitingIdiopathic Pulmonary Fibrosis (IPF) | Progressive Pulmonary FibrosisUnited Kingdom
-
Katerina M. AntoniouRecruitingIdiopathic Pulmonary Fibrosis (IPF) | Progressive Pulmonary Fibrosis | Fibrotic Interstitial Lungs DiseasesGreece
-
Peking Union Medical College HospitalRecruitingIdiopathic Retroperitoneal FibrosisChina
-
San Gerardo HospitalCompletedIdiopathic Pulmonary Fibrosis | Cardiac Fibrosis | Arterial FibrosisItaly
-
PureTechNot yet recruiting
-
St. Antonius HospitalZonMw: The Netherlands Organisation for Health Research and Development; Boeringer...RecruitingPulmonary Fibrosis Idiopathic FamilialNetherlands
-
Peking Union Medical College HospitalRecruiting
-
Peking Union Medical College HospitalRecruiting
-
Huan YeNot yet recruitingIdiopathic Pulmonary Fibrosis (IPF)China
-
Henan University of Traditional Chinese MedicineThe First Affiliated Hospital of Zhengzhou University; China-Japan Friendship... and other collaboratorsNot yet recruiting
Clinical Trials on the prevention of complications post-TIPS
-
Roswell Park Cancer InstituteWithdrawnPrimary Myelofibrosis | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma and other conditions
-
Southwest Oncology GroupNational Cancer Institute (NCI); Agency for Healthcare Research and Quality...CompletedUnspecified Adult Solid Tumor, Protocol Specific | Constipation, Impaction, and Bowel ObstructionUnited States, Canada, Colombia, Peru, Mexico
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedSpinal Cord Compression | Adult Spinal Cord Neoplasm | Spinal Bone MetastasesUnited States
-
Royal Marsden NHS Foundation TrustCompletedCancerUnited Kingdom
-
Security Forces HospitalCompletedFetal Complications | Pregnancy in DiabetesSaudi Arabia
-
Royal Marsden NHS Foundation TrustUnknownSarcoma | Cervical Cancer | Testicular Germ Cell Tumor | Colorectal Cancer | Ovarian Cancer | Prostate Cancer | Bladder Cancer | Endometrial Cancer | Radiation Toxicity | Vaginal Cancer | Gastrointestinal Complications | Long-term Effects Secondary to Cancer Therapy in AdultsUnited Kingdom
-
Azienda Ospedaliera di PadovaUnknownColorectal Cancer | Perioperative/Postoperative Complications | Gastrointestinal ComplicationsItaly
-
Université de SherbrookeCanadian Institutes of Health Research (CIHR)Recruiting
-
Vanderbilt UniversityNational Cancer Institute (NCI)Completed
-
Royal Marsden NHS Foundation TrustCompletedSarcoma | Cervical Cancer | Colorectal Cancer | Ovarian Cancer | Fallopian Tube Cancer | Bladder Cancer | Anal Cancer | Radiation Toxicity | Gastrointestinal ComplicationsUnited Kingdom